Wilentz, Goldman & Spitzer, P.A. announces the formation of its cross-disciplinary Cannabis Law group, established to respond to the needs of the firm’s clients in connection with New Jersey’s recently expanded legal medical marijuana program and the State’s potential enactment of an adult-use recreational program.
The group unites 17 lawyers from the firm’s employment, health law, pharmacy law, litigation, energy, banking and financial services, real estate, criminal defense and family law practice groups.
Members of the Wilentz Cannabis law group provide legal advice to employers, landlords, producers, patients, caregivers, dispensaries, physicians, hospitals, medical practices and others doing business in or impacted by the legal cannabis market. Two members of the group are also registered pharmacists. Members of the group also provide representation in matters arising from cannabis use, including employment concerns, and criminal defense and family matters.
The Wilentz Cannabis Law group is led by three shareholders: Angelo J. Cifaldi, co-co-chair of the firm’s Mass Tort and Class Action group, co-chair of the firm’s pharmacy law group and a member of the firm’s management committee; Michael F. Schaff, chair of the firm’s Corporate and Health Law groups and member of the firm’s management committee; and Roy H. Tanzman, a shareholder in the firm’s Commercial Real Estate group.
Angelo Cifaldi is also a registered pharmacist and an adjunct professor of Pharmacy Law and Bioethics at Rutgers College of Pharmacy. He has been advising the firm’s clients on the commercial and legal impact of New Jersey’s medical marijuana program since the program’s inception in 2010.
As the leader of Wilentz’s prominent Health Law practice, Michael Schaff represents physicians, hospitals and others doing business in the healthcare sector nationally. He is also a prolific speaker on health law and is co-editor of the October 2018 Special Edition of New Jersey Law Magazine focused on Cannabis Law.
Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance. Possession, use, distribution, and/or sale of cannabis is a federal crime and is subject to related federal policy, regardless of any state law that may authorize certain marijuana activity. Compliance with state marijuana law does not equal compliance with federal law. Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.